Epstein-Barr virus post-transplant lymphoproliferative disease (PTLD) after hematopoietic stem cell transplantation

被引：23
|
作者：
Ru, Yuhua [1 ,2 ]
Chen, Jia [1 ,2 ]
Wu, Depei [1 ,2 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou 215006, Peoples R China
[2] Soochow Univ, Collaborat Innovat Ctr Hematol, Inst Blood & Marrow Transplantat, Suzhou 215006, Peoples R China
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2018年 / 101卷 / 03期
基金：
美国国家科学基金会; 国家重点研发计划;
关键词：
EB virus; hematopoietic stem cell transplantation; lymphoproliferative disease; BONE-MARROW-TRANSPLANTATION; EBV REACTIVATION; RISK-FACTORS; VIRAL LOAD; PREEMPTIVE RITUXIMAB; PROLONGED HYPOGAMMAGLOBULINEMIA; ALLOGENEIC TRANSPLANTATION; HEART-TRANSPLANTATION; EUROPEAN CONFERENCE; PEDIATRIC-PATIENTS;
D O I：
10.1111/ejh.13131
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Epstein-Barr virus (EBV) viremia and post-transplant lymphoproliferative disease (PTLD) are severe complications after hematopoietic stem cell transplantation (HSCT). A series of risk factors have been found to predict EBV viremia and PTLD, including the T-cell depletion, reduced intensity conditioning, and alternative donor. The rituximab pre-emptive therapy could improve PTLD prognosis significantly, but the trigger of initiating rituximab pre-emptive therapy has not been well established. Additionally, EBV-specific cytotoxic T cell (CTL) is a promising approach to treat EBV-PTLD.
引用
收藏
页码：283 / 290
页数：8
相关论文
共 50 条
  • [41] Strategies for Epstein-Barr virus monitoring, detection and therapy in post-transplant lymphoproliferative disorder
    Nowalk, Andrew J.
    Green, Michael
    FUTURE VIROLOGY, 2007, 2 (04) : 369 - 376
  • [42] Epstein-Barr virus-associated posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation
    Sanz, Jaime
    Andreu, Rafael
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (06) : 677 - 683
  • [43] Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients
    San-Juan, R.
    Comoli, P.
    Caillard, S.
    Moulin, B.
    Hirsch, H. H.
    Meylan, P.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 : 109 - 118
  • [44] Association of Epstein-Barr virus infection with allogeneic hematopoietic stem cell transplantation in patients in Portugal
    Marinho-Dias, Joana
    Baldaque, Ines
    Pinho-Vaz, Carlos
    Leite, Luis
    Branca, Rosa
    Campilho, Fernando
    Campos, Antonio, Jr.
    Medeiros, Rui
    Sousa, Hugo
    MOLECULAR MEDICINE REPORTS, 2019, 19 (03) : 1435 - 1442
  • [45] Post-transplant lymphoproliferative disorder associated Epstein-Barr virus DNAemia after liver transplantation in children: Experience from single center
    Dogan, Barut
    Sema, Yildirim Arslan
    Bora, Kunay
    Veysel, Umman
    Benan, Dernek
    Ezgi, Kiran Tasci
    Gozde, Akkus Kayali
    Demir, Derya
    Ozsan, Nazan
    Hekimgil, Mine
    Zumrut, Sahbudak Bal
    Miray, Karakoyun
    Funda, Cetin
    Sema, Aydogdu
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (06)
  • [46] Quantitative Epstein-Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder
    Holman, Carol J.
    Karger, Amy B.
    Mullan, Beth D.
    Brundage, Richard C.
    Balfour, Henry H., Jr.
    CLINICAL TRANSPLANTATION, 2012, 26 (05) : 741 - 747
  • [47] Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction
    Omar, H.
    Hagglund, H.
    Gustafsson-Jernberg, A.
    LeBlanc, K.
    Mattsson, J.
    Remberger, M.
    Ringden, O.
    Sparrelid, E.
    Sundin, M.
    Winiarski, J.
    Yun, Z.
    Ljungman, P.
    TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (05) : 393 - 399
  • [48] Significance of Epstein-Barr Virus DNA Quantitation in Donors of Hematopoietic Stem Cell Transplantation
    Jung, Seungwon
    Lim, Jihyang
    Cho, Byung Sik
    Chae, Hyojin
    Kim, Myungshin
    Kim, Yonggoo
    Han, Kyungja
    Lee, Jong Wook
    Min, Woo Sung
    KOREAN JOURNAL OF LABORATORY MEDICINE, 2010, 30 (06): : 554 - 558
  • [49] Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients
    Patel, Chandni
    Pasciolla, Michelle
    Abramova, Rachel
    Salerno, David
    Gomez-Arteaga, Alexandra
    Shore, Tsiporah B.
    Orfali, Nina
    Mayer, Sebastian
    Hsu, Jingmei
    Phillips, Adrienne A.
    Chaekal, Ok-Kyong
    Satlin, Michael J.
    Soave, Rosemary
    Kodiyanplakkal, Rosy Priya L.
    Drelick, Alexander
    Plate, Markus
    Van Besien, Koen
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (02): : 132.e1 - 132.e5
  • [50] Monitoring of Epstein-Barr virus load in patients after allogeneic hematopoietic stem cell transplantation
    Volfova, P.
    Lengerova, M.
    Winterova, J.
    Racil, Z.
    Dvorakova, D.
    Mayer, J.
    INFECTION, 2012, 40 (05) : 583 - 587
12345